Lukasz Kaczynski

Commercial & Launch Strategy Director, International TA Immunology at Novartis | IMD MBA (with Honours) | ex-BCG

Zurich, Switzerland

About

I am a strategy and commercial leader with 13 years of International top tier consulting and industry experience across life sciences (Pharma and MedTech), financial services and investments industries. In life sciences, I gathered a wide cross-functional experience (Commercial & Launch Strategy, Marketing, Value & Access, Pricing and Medical) at International and in-country level (Germany, Japan) with a particular focus on developing corporate, business and launch strategies to achieve sustainable growth and competitive advantage. I am a resilient, well-balanced and authentic leader, strong analytical thinker and skilled relationship builder.

Experience

  • Commercial & Launch Strategy Director, International TA Immunology at Novartis
    Mar 2024 - Present · 2 yrs 4 mos

    Leading first in class asset launch in International markets with key focus on Germany, China and Japan.

  • TA Senior Strategy Lead Immunology (Japan) at Novartis Japan
    2025 - 2025 · Less than a year

    Leading local strategy and the cross-functional Team for the launch preparation of Remibrutinib Immunological indications in Japan

  • TA Strategy Lead, Immunology (Germany) -- Assignment at Novartis Deutschland
    2024 - 2024 · Less than a year

    Co-leading strategy & launch preparation for Remibrutinib Launch in CSU in Germany

  • Director Pharma Strategy at Novartis
    2021 - 2024 · 3 yrs

    As a Commercial Strategy Director, I am driving key strategic projects together with senior leadership of Novartis International, incl. scoping, structuring and leading cross-functional teams to execute these initiatives. SELECT PROJECT EXPERIENCE: • Jan 2024 onwards: In-country rotation (Germany) – Launch preparation co-lead for remibrutinib in CSU • Member (on assignment) of the Novartis Immunology Int’l TA Launch Team for remibrutinib in CSU – responsible for parts of the Int’l Launch Strategy (e.g. target patient definition) • Co-led Novartis-wide transformation and new OpModel implementation – i.a. strategic partner to program leadership and lead of the in-country OpModel design team (incl. onboarding of country GMs and facilitation of country LT immersion sessions - e.g. Spain, Japan) • Co-led a commercial transformation programme for Germany (Top3 NVS Int’l market)

  • Senior Strategy Manager at Monitor Deloitte
    2018 - 2021 · 3 yrs

    As a Senior Strategy Manager, I am carrying end-to-end project management responsibility, incl. the leadership, development and coaching of consulting teams. Additionally, I am responsible for a variety of business development activities (e.g. opportunity identification, project scoping, negotiations) SELECT PROJECT EXPERIENCE: • Led development of a global brand plan for a multi-billion drug in gastroenterology, incl. driving cross-functional alignment of over 40 stakeholders across multiple geographies • Supported major PharmaCo in overcoming System Hurdles while preparing for launching its 1st GTx asset • Developed patient-centricity strategy for a multiple-sclerosis blockbuster drug, incl. development and validation of patient centric initiatives with patients and industry experts • Led development of a European market-shaping strategy for osteoporosis for a biopharma company • Prepared and delivered training sessions in Market Access & Pricing (i.a. on innovative pricing models) for a global biopharma company • Led commercial capability development programme for a Global Pharma company